Arcus Biosciences, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2020-11-05: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2020-11-05: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2020-08-06: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2020-08-06: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2020-11-05 | 10-Q | Smaller reporting company | Yes |
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
| 2020-08-06 | 10-Q | Smaller reporting company | Yes |
| 2020-08-06 | 10-Q | Emerging growth company | Yes |
| 2020-05-05 | 10-Q | Smaller reporting company | Yes |
| 2020-05-05 | 10-Q | Emerging growth company | Yes |
| 2020-03-05 | 10-K | Smaller reporting company | Yes |
| 2020-03-05 | 10-K | Emerging growth company | Yes |
| 2020-03-05 | 10-K | Well-known seasoned issuer | No |
| 2019-11-05 | 10-Q | Smaller reporting company | Yes |
| 2019-11-05 | 10-Q | Emerging growth company | Yes |
| 2019-08-06 | 10-Q | Smaller reporting company | Yes |
| 2019-08-06 | 10-Q | Emerging growth company | Yes |
| 2019-05-02 | 10-Q | Smaller reporting company | Yes |
| 2019-05-02 | 10-Q | Emerging growth company | Yes |
| 2019-03-05 | 10-K | Emerging growth company | Yes |
| 2019-03-05 | 10-K | Well-known seasoned issuer | No |
| 2018-11-08 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |